Fresh Rounds

TenNor Therapeutics (Suzhou) Ltd funding

TenNor Therapeutics (Suzhou) Ltd, a biotechnology company based in Suzhou, China, filed a Form D with the SEC on May 26, 2026 and reported $14.7M raised.

Amount raised$14.7M
Offering size$14.7M
Filed with the SECMay 26, 2026
First saleMay 12, 2026
IndustryBiotechnology
SecuritiesEquity
LocationSuzhou, China
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeNo Revenues

Other health care rounds